Today's Marketplace (TMP) is proud to announce a featured interview with Ensysce Biosciences (NASDAQ: ENSC) CEO Dr. Lynn ...

Widespread access to opioid agonist treatment (OAT) can reduce the risk of suicide by 35% among people with opioid use ...

With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain ...

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, ...

Neurosurgeon and scientist Dr. Jandial joined us to discuss a major breakthrough in pain medication recently approved by the FDA. It is the first opioid-free painkiller of its kind in more than 20 ...

Older adults are not immune from the opioid crisis, but senior living can provide safeguards through medication management to help control chronic conditions and effectively mitigate pain, Argentum ...

The Food and Drugs Authority (FDA) has revoked the Good Manufacturing Practices (GMP) certification of Aveo Pharmaceuticals, ...

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

Widespread access to opioid agonist treatment (OAT) can reduce the risk of suicide by 35% among people with opioid use disorder, according to a new ...

The bill also says this does not include programs or practitioners that issue prescriptions for partial opioid agonist ...